Atlas Trials

A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma

Clinical trial NCT05077280 · UNKNOWN

Trial details

NCT number
NCT05077280
Sponsor
California Pacific Medical Center Research Institute
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Uveal Melanoma
Start date
2021-09-20
Primary completion
2024-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.